Aspect Biosystems Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 110

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $115M

  • Investors
  • 37

Aspect Biosystems General Information

Description

Developer of a full-stack tissue therapeutic platform designed to innovate at the intersection of biology, medicine, and engineering to build living human tissues. The company's platform offers proprietary microfluidic three-dimensional bioprinting technology that creates advances in understanding fundamental biology, disease research, development of novel therapeutics, and regenerative medicine, enabling researchers to understand the creation of human tissues for medical research, therapeutic discovery, and medicine products.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 887 Great Northern Way
  • Suite 500
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604)
Primary Industry
Biotechnology
Corporate Office
  • 887 Great Northern Way
  • Suite 500
  • Vancouver, British Columbia V5T 4T5
  • Canada
+1 (604)

Aspect Biosystems Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aspect Biosystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Later Stage VC (Series B) 08-Jan-2025 $115M Completed Generating Revenue
14. Grant 10-Jul-2024 Completed Generating Revenue
13. Accelerator/Incubator Completed Generating Revenue
12. Later Stage VC 12-Apr-2023 Completed Generating Revenue
11. Grant 20-Mar-2023 Completed Generating Revenue
10. Secondary Transaction - Private Completed Generating Revenue
9. Later Stage VC (Series A) 01-Jun-2020 Completed Generating Revenue
8. Grant 15-Nov-2018 Completed Generating Revenue
7. Later Stage VC 15-Mar-2018 $783K $783K Completed Generating Revenue
6. Early Stage VC 31-Jul-2017 Completed Generating Revenue
To view Aspect Biosystems’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Aspect Biosystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a full-stack tissue therapeutic platform designed to innovate at the intersection of biology, medicine, and
Biotechnology
Vancouver, Canada
110 As of 2025

Villaz-Saint-Pierre, Switzerland
 

Schlieren, Switzerland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aspect Biosystems Competitors (9)

One of Aspect Biosystems’s 9 competitors is REGENHU, a Venture Capital-Backed company based in Villaz-Saint-Pierre, Switzerland.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
REGENHU Venture Capital-Backed Villaz-Saint-Pierre, Switzerland
InSphero Venture Capital-Backed Schlieren, Switzerland
Synthecon Formerly Accelerator/Incubator backed Houston, TX
VoxCell BioInnovation Venture Capital-Backed Victoria, Canada
VivoSim Labs Formerly VC-backed San Diego, CA
You’re viewing 5 of 9 competitors. Get the full list »

Aspect Biosystems Patents

Aspect Biosystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023271390-A1 Systems and methods for fabricating bioprinted fiber structures Pending 15-May-2022
AU-2023273544-A1 Compositions and methods for treating diabetes Pending 15-May-2022
EP-4526102-A1 Systems and methods for fabricating bioprinted fiber structures Pending 15-May-2022
EP-4525894-A1 Compositions and methods for treating diabetes Pending 15-May-2022
AU-2022408220-A1 Radial pump assembly and methods of using same Pending 16-Dec-2021 B29C64/336
To view Aspect Biosystems’s complete patent history, request access »

Aspect Biosystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aspect Biosystems Investors (37)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dimension (United States) Venture Capital Minority
InBC Investment Venture Capital Minority
T1D Fund Venture Capital Minority
British Columbia Ministry of Economic Development Government
Novo Nordisk Corporation
You’re viewing 5 of 37 investors. Get the full list »

Aspect Biosystems FAQs

  • When was Aspect Biosystems founded?

    Aspect Biosystems was founded in 2013.

  • Where is Aspect Biosystems headquartered?

    Aspect Biosystems is headquartered in Vancouver, Canada.

  • What is the size of Aspect Biosystems?

    Aspect Biosystems has 110 total employees.

  • What industry is Aspect Biosystems in?

    Aspect Biosystems’s primary industry is Biotechnology.

  • Is Aspect Biosystems a private or public company?

    Aspect Biosystems is a Private company.

  • What is Aspect Biosystems’s current revenue?

    The current revenue for Aspect Biosystems is .

  • How much funding has Aspect Biosystems raised over time?

    Aspect Biosystems has raised $211M.

  • Who are Aspect Biosystems’s investors?

    Dimension (United States), InBC Investment, T1D Fund, British Columbia Ministry of Economic Development, and Novo Nordisk are 5 of 37 investors who have invested in Aspect Biosystems.

  • Who are Aspect Biosystems’s competitors?

    REGENHU, InSphero, Synthecon, VoxCell BioInnovation, and VivoSim Labs are some of the 9 competitors of Aspect Biosystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »